Abstract:Abstract Motivation Traditional drug discovery and development are often time-consuming and high risk. Repurposing/repositioning of approved drugs offers a relatively low-cost and high-efficiency approach toward rapid development of efficacious treatments. The emergence of large-scale, heterogeneous biological networks has offered unprecedented opportunities for developing in silico drug repositioning approaches. However, capturing highly non-linear, heterogeneous network structures by most existing approaches for drug repositioning has been challenging. Results In this study, we developed a network-based deep-learning approach, termed deepDR, for in silico drug repurposing by integrating 10 networks: one drug–disease, one drug-side-effect, one drug–target and seven drug–drug networks. Specifically, deepDR learns high-level features of drugs from the heterogeneous networks by a multi-modal deep autoencoder. Then the learned low-dimensional representation of drugs together with clinically reported drug–disease pairs are encoded and decoded collectively via a variational autoencoder to infer candidates for approved drugs for which they were not originally approved. We found that deepDR revealed high performance [the area under receiver operating characteristic curve (AUROC) = 0.908], outperforming conventional network-based or machine learning-based approaches. Importantly, deepDR-predicted drug–disease associations were validated by the ClinicalTrials.gov database (AUROC = 0.826) and we showcased several novel deepDR-predicted approved drugs for Alzheimer’s disease (e.g. risperidone and aripiprazole) and Parkinson’s disease (e.g. methylphenidate and pergolide). Availability and implementation Source code and data can be downloaded from https://github.com/ChengF-Lab/deepDR Supplementary information Supplementary data are available online at Bioinformatics.

A geometric deep learning framework for drug repositioning over heterogeneous information networks

A Novel Graph Representation Learning Model for Drug Repositioning Using Graph Transition Probability Matrix over Heterogenous Information Networks.

Drug repositioning with adaptive graph convolutional networks

Geometric Deep Learning for Drug Discovery

deepDR: a network-based deep learning approach to in silico drug repositioning

Drug Repositioning by Collaborative Learning Based on Graph Convolutional Inductive Network

Regulation-aware graph learning for drug repositioning over heterogeneous biological network

Drug repositioning based on the heterogeneous information fusion graph convolutional network

Drug Repositioning by Multi-Aspect Heterogeneous Graph Contrastive Learning and Positive-Fusion Negative Sampling Strategy

In Silico Drug Repositioning Using Deep Learning and Comprehensive Similarity Measures

DeepDrug: A General Graph-Based Deep Learning Framework for Drug-Drug Interactions and Drug-Target Interactions Prediction

REDDA: Integrating multiple biological relations to heterogeneous graph neural network for drug-disease association prediction

Drug repositioning based on weighted local information augmented graph neural network

Multi-level Subgraph Representation Learning for Drug-Disease Association Prediction over Heterogeneous Biological Information Network.

H2D: Hierarchical Heterogeneous Graph Learning Framework for Drug-Drug Interaction Prediction

A Fused Deep Learning Approach to Transform Novel Drug Repositioning

Fusing Higher and Lower-Order Biological Information for Drug Repositioning Via Graph Representation Learning

Drug Repositioning Method Based on Deep Neural Network

DRONet: effectiveness-driven drug repositioning framework using network embedding and ranking learning

A weighted bilinear neural collaborative filtering approach for drug repositioning

A spatial hierarchical network learning framework for drug repositioning allowing interpretation from macro to micro scale